Cargando…
Pancreatitis as immune‐related adverse event during pembrolizumab therapy for multiple lung metastases from renal pelvic cancer
INTRODUCTION: Pembrolizumab administration has become the standard of care for patients with urothelial carcinoma, though a variety of adverse events have been reported. Presented here is a rare case of pancreatitis that occurred as an immune‐related adverse event. CASE PRESENTATION: An 81‐year‐old...
Autores principales: | Kokura, Kazuki, Watanabe, Jun, Takuma, Takaaki, Yokozeki, Hitoshi, Uketa, Shoko, Uemura, Yuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622221/ https://www.ncbi.nlm.nih.gov/pubmed/37928307 http://dx.doi.org/10.1002/iju5.12633 |
Ejemplares similares
-
A case of Avelumab response to multiple bone and lymph node metastases of plasmacytoid variant bladder cancer
por: Kokura, Kazuki, et al.
Publicado: (2023) -
A case of renal schwannoma
por: Kokura, Kazuki, et al.
Publicado: (2022) -
Successful Resection of Cisplatin-Resistant Renal Pelvic Cancer after the Administration of Pembrolizumab as Second-Line Therapy
por: Kawahara, Takashi, et al.
Publicado: (2019) -
A case of bladder perivascular epithelioid cell tumors
por: Kokura, Kazuki, et al.
Publicado: (2022) -
Pembrolizumab‐caused polyradiculoneuropathy as an immune‐related adverse event
por: Kurashige, Takashi, et al.
Publicado: (2021)